Search clinical trials for: Placebo

Total 53479 results

GlaxoSmithKline

Completed

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Cognition Therapeutics
National Institute on Aging (NIA)

Completed

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Alzheimer Disease

Netherlands
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller

Asthma

United States, Germany, Poland, Argentina, Peru
AstraZeneca

Withdrawn

Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study (PROTECT)

Neurofibromatosis Type 1 | Plexiform Neurofibromas | Post-operative

China
Haisco Pharmaceutical Group Co., Ltd.

Completed

Single Escalating Dose Study Of HSK7653 In Healthy Subjects

T2DM (Type 2 Diabetes Mellitus)

China
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Trial of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Keymed Biosciences Co.Ltd

Active, not recruiting

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps (DUBHE)

Chronic Rhinosinusitis With Nasal Polyps

China
Lateral Pharma Pty Ltd
Southern Star Research Pty Ltd.

Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Radiculopathy Lumbar

Australia
RSV Therapeutics LLC

Completed

A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19

Sars-CoV-2 Infection

Russian Federation
São Paulo State University

Completed

Massage as Recovery Strategy After Resistance Training

Resistance Training

Brazil
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.

Uremic Pruritus

Japan
Eli Lilly and Company

Completed

A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain

Chronic Low-back Pain

United States, Puerto Rico
FSD Pharma, Inc.

Terminated

Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)

Mast Cell Activation Syndrome | Mast Cell Activation Disorder Idiopathic

Canada, United States
Aristea Therapeutics, Inc.

Terminated

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Palmoplantar Pustulosis

United States, Canada, Germany, Poland, Czechia, Hungary, United Kingdom
Ingredia S.A.
BioTeSys GmbH

Completed

Clinical Study to Assess the Long-term Effect of Pep2Dia® on Glucose Homeostasis in Prediabetic Subjects

Prediabetic State

Germany
Momenta Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

United States, Belgium, Canada, Germany, Italy, Poland, Spain, United Kingdom
EpiEndo Pharmaceuticals
FGK Clinical Research GmbH

Completed

Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults

Chronic Obstructive Pulmonary Disease | COPD

Germany
APRINOIA Therapeutics, LLC

Active, not recruiting

A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Alzheimer Disease | Tauopathies | Healthy Volunteers

United States
Jeffrey B. Schwimmer, MD

Active, not recruiting

C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome

Metabolic Syndrome

United States
Pusan National University Hospital

Completed

The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease

Laryngopharyngeal Reflux Disease

Korea, Republic of
Guangdong Raynovent Biotech Co., Ltd

Completed

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

Mild to Moderate COVID-19

China
Novartis Pharmaceuticals

Completed

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Atopic Dermatitis

Germany, Czechia, Hungary, France, Spain, Poland
AnaMar AB
Covance

Completed

Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects

Tolerability | Safety

United Kingdom
Cascade Pharmaceuticals, Inc

Completed

Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects

Primary Biliary Cholangitis

China
Freya Biosciences ApS

Completed

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (DYSCOVER-1)

Vaginal Flora Imbalance

Ireland
AstraZeneca

Completed

Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants

Idiopathic Pulmonary Fibrosis

United States
Akero Therapeutics, Inc

Active, not recruiting

A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

NASH - Nonalcoholic Steatohepatitis

United States, Mexico, Puerto Rico
Shanghai Junshi Bioscience Co., Ltd.

Completed

The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

Hyperlipemia

China
Biogen

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Biogen

Completed

Study to Evaluate DNL151 in Subjects With Parkinson's Disease

Parkinson's Disease

Belgium, United States, United Kingdom, Netherlands
Shenzhen Turier Biotech Co., Ltd

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of TB001 in Healthy Subjects

Healthy

China
Taichung Veterans General Hospital

Completed

The Effects of Yogurt on Gut Microbiome and Metabolism in H. Pylori.

Insulin Resistance | Helicobacter Pylori Infection | Gut Microbiota | Probiotic

Taiwan
National Taiwan University Hospital

Terminated

Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy

Multiple System Atrophy | Ataxia, Cerebellar

Taiwan
Taichung Veterans General Hospital
Grape King Bio Ltd.

Enrolling by invitation

Probiotic Supplements in Chronic Kidney Disease

Chronic Kidney Disease

Taiwan
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis (AD)

Atopic Dermatitis

China
Novartis Pharmaceuticals

Terminated

A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)

Sjogren Syndrome | Mixed Connective Tissue Disease

Spain, Hungary, Germany, China, Poland, Taiwan
Young-Hak Kim, MD, PhD

Completed

Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention (DAPTALBIS)

Gastritis | Gastroduodenal Ulcer

Korea, Republic of
University of Manitoba
Lallemand Health Solutions

Completed

Impact of Probiotics on Weight Control and Body Composition in Overweight and Obese Individuals

Obesity

Canada
Helsinki University Central Hospital
Odense University Hospital; University of Oslo; Sahlgrenska University Hospital... and other collaborators

Completed

The Effect of BATon BP and Sympathetic Function in Resistant Hypertension (The Nordic BAT Study) (BAT)

Resistant Hypertension

Denmark, Sweden, Finland, Norway
Finch Research and Development LLC.

Terminated

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) (PRISM4)

Recurrent C. Difficile Infection

United States, Canada
Bionomics Limited

Completed

Phase II Study of BNC210 in PTSD (RESTORE)

Post-Traumatic Stress Disorder

United States, Australia
Zealand Pharma

Withdrawn

Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults

Glucose Metabolism Disorders | Hypoglycemia
Chugai Pharmaceutical

Completed

A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer

Healthy Volunteers

Netherlands
Virogenics, Inc.
National Institute on Aging (NIA); Celerion

Completed

Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects (CMS121)

Alzheimer Disease

United States
Evopoint Biosciences Inc.

Completed

The the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XNW3009 in Health Subject

Gout

Australia
Hoffmann-La Roche

Completed

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Alzheimer's Disease

Canada, United States, Spain, Korea, Republic of, Belgium, United Kingdom, Australia, Germany, Portugal, Argentina, Bulgaria, Denmark, Finland, France, Hungary, Italy, Japan, Netherlands, Russian Federation, Sweden, Switzerland, T...
Genentech, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia (EMPACTA)

COVID-19 Pneumonia

United States, Peru, Kenya, Mexico, Brazil, South Africa
Materia Medica Holding

Completed

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

Post-acute COVID-19 Syndrome

Russian Federation
Merck Sharp & Dohme LLC

Terminated

Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)

Coronavirus Disease (COVID-19)

Colombia, United States, Brazil, Canada, Chile, France, Israel, Italy, Korea, Republic of, Mexico, Philippines, Poland, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
AstraZeneca
PRA Health Sciences

Completed

Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus (TULIP SLE LTE)

Active Systemic Lupus Erythematosus

United States, France, Germany, Spain, Russian Federation, Peru, Taiwan, United Kingdom, Japan, Korea, Republic of, Argentina, Israel, Hungary, Bulgaria, Romania, Australia, Ukraine, Mexico, Canada, South Africa, Poland, Lithuania, ... and more

Search clinical trials for: Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations